back
09 Mar 2022

DPI CDC annonce accord avec KELIX bio pour acquérir PHI lors d’un 2ème

https://www.dpi-llp.com/wp-content/uploads/2022/03/DPI-CDC-annonce-accord-avec-KELIX-bio-pour-acquerir-PHI-lors-dun-2eme-Final.pdf

Related articles

DPI CDC announce KELIX bio agreement to acquire PHI $200m second funding round
| 09 Mar 2022
DPI Impact and ESG
| 13 Jan 2022
DPI has been awarded the Private Equity Africa 2021 House, Large and Mid Cap deals of the year for its investments in Kelix Bio and SICAM.
| 06 Dec 2021
See all news
Copyright © DPI 2022